wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37838448-0ACB87F2-81D5-4900-B2E4-F552929366A5
Q37838448-0ACB87F2-81D5-4900-B2E4-F552929366A5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37838448-0ACB87F2-81D5-4900-B2E4-F552929366A5
Present and future therapeutic options for locally advanced and metastatic renal cell carcinoma.
P2860
Q37838448-0ACB87F2-81D5-4900-B2E4-F552929366A5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37838448-0ACB87F2-81D5-4900-B2E4-F552929366A5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9ab5e2d7a58869b5cdea32607d91b936e458b869
P2860
A phase II, open-label study of gefitinib (IRESSA) in patients with locally advanced, metastatic, or relapsed renal-cell carcinoma.